// App-Quantinova.ai

: MLL-AF4 CAUSES ABERRANT UPREGULATION OF PROM1 (CD133) IN ACUTE LYMPHOBLASTIC LEUKEMIA BY CONTROLLING ENHANCER-PROMOTER INTERACTIONS

Researchers

Presenter

  • Laura Godfrey

Principal Investigators

  • Sorcha O'Byrne

  • Nicholas T Crump

  • I-Jun Lau

  • Ross Thorne

  • Natalina Elliott

  • Gemma Buck

  • Siobhan Rice

  • Christopher Connor

  • Rebecca Thomas

  • Danny Cheng

  • Philip Ancliff

  • Sarah Inglott

  • Irene Roberts

  • Anindita Roy

  • Thomas A Milne

Medical Centers

  • MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  • Department of Oncology, University of Oxford, Oxford, United Kingdom

  • Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom

  • The MRC Weatherall Institute of Molecular Medicine,University of Oxford,Oxford,United Kingdom;Department of Paediatrics,University of Oxford,Oxford,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Prominin 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved